Motif ID	Motif Logo	Scanned Score Distribution	Frequency of Motif	Replicability Score	Evolutionary Conservation Score	Gene Targets	Gene Ontology of CpGMM targets
CG_h1r2_promoter_p_PM_12_51_9			1	0.25	8.80E-05	P2RX2	detection of hypoxic conditions in blood by carotid body chemoreceptor signaling [BP], nickel cation binding [MF], mercury ion binding [MF]
CG_h1r2_promoter_p_PM_12_58_9			4	0.5	2.19E-05	PRMT2	progesterone receptor binding [MF]
CG_h1r2_promoter_p_PM_12_227_13			3	0.75	6.25E-05	SDCCAG8, SNCAIP	tube formation [BP], dopamine metabolic process [BP]
CG_h1r2_promoter_p_PM_12_226_7			1	0.25	1.55E-04	NCOA1, CEL, CAMKMT	calmodulin-lysine N-methyltransferase activity [MF], protein esterification [BP], positive regulation of transcription from RNA polymerase II promoter by galactose [BP], intestinal lipid catabolic process [BP]
CG_h1r2_promoter_p_PM_12_220_8			2	0.25	2.57E-04	DCK	deoxycytidine kinase activity [MF]
CG_h1r2_promoter_p_PM_12_181_12			3	0.75	9.08E-05	ATP12A, QPRT	hydrogen:potassium-exchanging ATPase complex [CC], quinolinate catabolic process [BP]
CG_h1r2_promoter_p_PM_12_248_5			1	0.25	2.54E-05	ADPRM	CDP-glycerol diphosphatase activity [MF]
CG_h1r2_promoter_p_PM_12_180_16			1	0.25	4.79E-05	NFKB2	follicular dendritic cell differentiation [BP], Bcl3/NF-kappaB2 complex [CC]
CG_h1r2_promoter_p_PM_12_325_4			1	0.25	1.17E-05	DNAJB2	negative regulation of inclusion body assembly [BP], negative regulation of protein deubiquitination [BP]
CG_h1r2_promoter_p_PM_12_236_7			2	0.5	9.19E-05	DRD5, GLYCTK, FCAR	norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure [BP], dopamine neurotransmitter receptor activity, coupled via Gs [MF], sensitization [BP], regulation of systemic arterial blood pressure by vasopressin [BP], negative regulation of NAD(P)H oxidase activity [BP], glycerate kinase activity [MF], IgA binding [MF]
CG_h1r2_promoter_p_PM_12_263_8			2	0.5	1.43E-05	TCF7L1, CAMSAP3	positive regulation of transcription from RNA polymerase II promoter during mitosis [BP], microtubule minus-end binding [MF]
CG_h1r2_promoter_p_PM_12_267_13			1	0.25	1.61E-04	ROMO1, CHCHD6, UQCR10, DCSTAMP, ING5, ING1, ATP5D, NDUFV2	methylated histone residue binding [MF], oxidative phosphorylation [BP], negative regulation of growth [BP], mitochondrial inner membrane [CC], osteoclast fusion [BP], respiratory electron transport chain [BP]
CG_h1r2_promoter_p_PM_12_56_7			1	0.25	2.62E-05	TRIP10	cell projection [CC]
CG_h1r2_promoter_p_PM_12_85_8			1	0.25	5.09E-05	CAMP, OPRM1	beta-endorphin receptor activity [MF], cell wall [CC], morphine receptor activity [MF], negative regulation of growth of symbiont on or near host surface [BP], negative regulation of Wnt protein secretion [BP]
CG_h1r2_promoter_p_PM_12_258_9			2	0.5	1.28E-04	PAFAH1B1	astral microtubule [CC], establishment of centrosome localization [BP]
CG_h1r2_promoter_p_PM_12_173_6			1	0.25	3.12E-04	FGF2, HAO2	substantia nigra development [BP], mandelate metabolic process [BP]
CG_h1r2_promoter_p_PM_12_265_9			3	0.5	3.04E-05	IL1RN	interleukin-1 Type II receptor antagonist activity [MF], interleukin-1 Type I receptor antagonist activity [MF]
CG_h1r2_promoter_p_PM_12_108_17			1	0.25	2.98E-05	F2R	negative regulation of renin secretion into blood stream [BP]
CG_h1r2_promoter_p_PM_12_60_10			2	0.25	1.76E-04	TIRAP	Toll-like receptor 2 binding [MF], TIRAP-dependent toll-like receptor 4 signaling pathway [BP], positive regulation of toll-like receptor 2 signaling pathway [BP], positive regulation of chemokine (C-X-C motif) ligand 1 production [BP], positive regulation of interleukin-15 production [BP]
CG_h1r2_promoter_p_PM_12_282_4			2	0.5	4.71E-05	GTPBP4, PLK1, BLM	regulation of binding [BP], regulation of cyclin-dependent protein kinase activity [BP], G2/M transition DNA damage checkpoint [BP], negative regulation of DNA replication [BP]
CG_h1r2_promoter_p_PM_12_283_10			2	0.5	9.92E-06	AGL, VPS4A, ZDHHC17	isoamylase complex [CC], glycogen debranching enzyme activity [MF], amylo-alpha-1,6-glucosidase activity [MF], 4-alpha-glucanotransferase activity [MF], protein-cysteine S-palmitoleyltransferase activity [MF], ESCRT III complex [CC]
CG_h1r2_promoter_p_PM_12_72_8			2	0.5	8.15E-05	ABP1, USP42, USP8	diamine oxidase activity [MF], cellular response to azide [BP], histamine oxidase activity [MF], cellular response to copper ion starvation [BP], protein deubiquitination [BP], methylputrescine oxidase activity [MF], propane-1,3-diamine oxidase activity [MF], ubiquitin thiolesterase activity [MF]
CG_h1r2_promoter_p_PM_12_140_5			1	0.25	8.43E-05	NDUFV2, PHYHD1, ARL6, OBSCN	metal ion binding [MF]
CG_h1r2_promoter_p_PM_12_205_16			1	0.25	2.42E-05	ITK	NK T cell differentiation [BP]
CG_h1r2_promoter_p_PM_12_74_7			2	0.5	4.68E-05	SQRDL, ZNF175, IFT88, PTPRC, TPGS1, DNAH2	cilium [CC], sulfide:quinone oxidoreductase activity [MF], defense response to virus [BP], cilium axoneme [CC], microtubule basal body [CC], motile cilium [CC]
CG_h1r2_promoter_p_PM_12_322_12			2	0.5	1.31E-04	GNA15, SLC9A3R1	phospholipase C-activating dopamine receptor signaling pathway [BP]
CG_h1r2_promoter_p_PM_12_107_13			3	0.5	1.80E-04	SLC5A1	glucose:sodium symporter activity [MF]
CG_h1r2_promoter_p_PM_12_215_11			2	0.5	3.77E-05	AGTR1, WFS1, FMO3, NUDT9	trimethylamine monooxygenase activity [MF], angiotensin type I receptor activity [MF], ADP catabolic process [BP], negative regulation of type B pancreatic cell apoptotic process [BP], phospholipase C-activating angiotensin-mediated signaling pathway [BP], intrinsic to endoplasmic reticulum membrane [CC]
CG_h1r2_promoter_p_PM_12_239_7			1	0.25	1.85E-04	AZU1, ALG1	positive regulation of fractalkine biosynthetic process [BP], chitobiosyldiphosphodolichol beta-mannosyltransferase activity [MF], positive regulation of interleukin-1 beta biosynthetic process [BP]
CG_h1r2_promoter_p_PM_12_193_6			2	0.5	3.42E-05	SLC6A2, BMPR1A	paraxial mesoderm structural organization [BP], norepinephrine:sodium symporter activity [MF], neural plate mediolateral regionalization [BP]
CG_h1r2_promoter_p_PM_12_186_7			3	0.5	5.83E-05	SLC13A2	low affinity sodium:dicarboxylate symporter activity [MF]
CG_h1r2_promoter_p_PM_12_111_8			2	0.5	4.27E-05	PRLH, PLCL2, NLGN1, EDNRA	neurexin clustering [BP], prolactin-releasing peptide receptor binding [MF], positive regulation of synaptic vesicle endocytosis [BP], phosphatidylinositol phospholipase C activity [MF], cytoskeletal matrix organization at active zone [BP], positive regulation of synaptic vesicle exocytosis [BP]
CG_h1r2_promoter_p_PM_12_219_8			2	0.25	5.95E-05	ASRGL1, WNT8B	negative regulation of anterior neural cell fate commitment of the neural plate by Wnt receptor signaling pathway [BP], asparagine catabolic process via L-aspartate [BP]
CG_h1r2_promoter_p_PM_12_7_5			1	0.25	3.19E-05	GATC, DOLPP1	regulation of translational fidelity [BP], dolichyl diphosphate biosynthetic process [BP], dolichyldiphosphatase activity [MF]
CG_h1r2_promoter_p_PM_12_331_7			3	0.5	5.82E-05	NR1H3, HELT	GABAergic neuron differentiation in basal ganglia [BP], negative regulation of secretion of lysosomal enzymes [BP]
CG_h1r2_promoter_p_PM_12_164_9			1	0.25	1.91E-05	LDLR, NOP58, SPIRE2, SPHK2	snRNP protein import into nucleus [BP], phospholipid transport [BP], intracellular transport [BP], sphinganine-1-phosphate biosynthetic process [BP]
CG_h1r2_promoter_p_PM_12_145_12			3	0.75	4.80E-05	SMARCA2	aortic smooth muscle cell differentiation [BP]
CG_h1r2_promoter_p_PM_12_210_11			2	0.5	1.49E-04	PCDHB3, PSEN1, NUPL1, ABL1, PEX13, FBXO45	L-glutamate transport [BP], nuclear envelope [CC], cerebral cortex cell migration [BP], nuclear membrane [CC], nervous system development [BP]
CG_h1r2_promoter_p_PM_12_48_7			2	0.5	1.26E-04	NOD2, COPS6	signalosome [CC]
CG_h1r2_promoter_p_PM_12_68_11			2	0.5	4.70E-05	NAA60, GLYCTK	N-terminal peptidyl-methionine acetylation [BP], glycerate kinase activity [MF]
CG_h1r2_promoter_p_PM_12_119_11			2	0.5	1.85E-05	HSD11B2, FGFR4	regulation of blood volume by renal aldosterone [BP], 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity [MF], alveolar secondary septum development [BP]
CG_h1r2_promoter_p_PM_12_134_7			1	0.25	9.08E-05	HGS, FZD7, DENND3	endosome to lysosome transport [BP], negative regulation of ectodermal cell fate specification [BP]
CG_h1r2_promoter_p_PM_12_160_7			1	0.25	2.82E-04	ABAT, SERPINA5	4-aminobutyrate transaminase activity [MF], (S)-3-amino-2-methylpropionate transaminase activity [MF], protein C inhibitor-PLAT complex [CC], protein C inhibitor-thrombin complex [CC], protein C inhibitor-coagulation factor V complex [CC], succinate-semialdehyde dehydrogenase binding [MF], protein C inhibitor-TMPRSS7 complex [CC], acrosin binding [MF], protein C inhibitor-coagulation factor Xa complex [CC], protein C inhibitor-plasma kallikrein complex [CC], gamma-aminobutyric acid catabolic process [BP], 4-aminobutyrate transaminase complex [CC], protein C inhibitor-TMPRSS11E complex [CC], protein C inhibitor-coagulation factor XI complex [CC], protein C inhibitor-PLAU complex [CC], protein C inhibitor-KLK3 complex [CC]
CG_h1r2_promoter_p_PM_12_87_7			1	0.25	6.60E-05	SPO11	zygotene [BP]
CG_h1r2_promoter_p_PM_12_278_9			1	0.25	2.13E-05	HTR3A, EGFR	Shc-EGFR complex [CC], activation of phospholipase A2 activity by calcium-mediated signaling [BP], serotonin-activated cation-selective channel activity [MF]
CG_h1r2_promoter_p_PM_12_79_12			2	0.5	1.84E-04	IRAK3	negative regulation of innate immune response [BP]
CG_h1r2_promoter_p_PM_12_103_19			1	0.25	2.40E-05	DAG1, TDP1, TANC1	dendritic spine maintenance [BP], 3'-tyrosyl-DNA phosphodiesterase activity [MF], nerve maturation [BP]
CG_h1r2_promoter_p_PM_12_321_5			2	0.5	5.83E-05	TBC1D14	regulation of autophagic vacuole assembly [BP]
CG_h1r2_promoter_p_PM_12_274_11			2	0.5	1.50E-04	KLHL41, SMARCA2, MSMO1	regulation of lateral pseudopodium assembly [BP], aortic smooth muscle cell differentiation [BP], C-4 methylsterol oxidase activity [MF]
CG_h1r2_promoter_p_PM_12_318_12			3	0.5	1.64E-04	CTCF, NAGK, CHST4	N-acetylglucosamine kinase activity [MF], chromatin insulator sequence binding [MF], N-acetylglucosamine metabolic process [BP]
CG_h1r2_promoter_p_PM_12_261_10			1	0.25	5.31E-06	NMRK2, TUB	multicellular organismal macromolecule metabolic process [BP], phagocytosis [BP], ribosylnicotinamide kinase activity [MF]
CG_h1r2_promoter_p_PM_12_112_5			1	0.25	6.65E-05	CORO1A	negative regulation of actin nucleation [BP]
CG_h1r2_promoter_p_PM_12_139_10			2	0.5	4.69E-05	EP300	lysine N-acetyltransferase activity [MF]
CG_h1r2_promoter_p_PM_12_25_8			1	0.25	4.86E-05	PDZD3, FOXJ2, HSD17B6, MIXL1	androgen catabolic process [BP], subapical complex [CC], positive regulation of mesoderm development [BP], negative regulation of cGMP biosynthetic process [BP], negative regulation of guanylate cyclase activity [BP], guanylate cyclase inhibitor activity [MF], RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity [MF]
CG_h1r2_promoter_p_PM_12_65_12			2	0.5	2.09E-04	SLC5A3, PTGR2, DOLPP1	dolichyl diphosphate biosynthetic process [BP], myo-inositol:sodium symporter activity [MF], dolichyldiphosphatase activity [MF], 15-oxoprostaglandin 13-oxidase activity [MF], 13-prostaglandin reductase activity [MF]
CG_h1r2_promoter_p_PM_12_292_10			1	0.25	7.88E-05	HMGA2, WBP4, DCPS	histone H2A-S139 phosphorylation [BP], chromosome breakage [BP], mesodermal-endodermal cell signaling [BP], mRNA cis splicing, via spliceosome [BP], negative regulation of double-strand break repair via nonhomologous end joining [BP], positive regulation of cellular response to X-ray [BP]
CG_h1r2_promoter_p_PM_12_211_9			2	0.5	7.40E-05	ATP6V1A, AK7, ACSM3, CDC34, CKMT1A, PPIP5K2, PDXK	ATP binding [MF]
CG_h1r2_promoter_p_PM_12_298_4			2	0.5	7.43E-05	SHROOM2	eye pigment granule organization [BP]
CG_h1r2_promoter_p_PM_12_136_8			1	0.25	7.32E-05	AZU1	positive regulation of fractalkine biosynthetic process [BP], positive regulation of interleukin-1 beta biosynthetic process [BP]
CG_h1r2_promoter_p_PM_12_57_6			2	0.5	5.31E-05	KLC2	kinesin I complex [CC]
CG_h1r2_promoter_p_PM_12_254_6			2	0.5	2.03E-04	IL18BP, EGR1, PHF2, PDCD1LG2	interleukin-18 binding [MF], response to norepinephrine stimulus [BP], positive regulation of glomerular metanephric mesangial cell proliferation [BP], cellular response to mycophenolic acid [BP], negative regulation of chromatin silencing at rDNA [BP], cellular response to isoquinoline alkaloid [BP], immune response [BP]
CG_h1r2_promoter_p_PM_12_280_8			2	0.5	3.07E-05	BBS4, CREB1, LMO4	enhancer sequence-specific DNA binding [MF], positive regulation of multicellular organism growth [BP], positive regulation of flagellum assembly [BP]
CG_h1r2_promoter_p_PM_12_203_6			3	0.5	1.92E-04	DPEP1, ZFPM1	transcriptional activation by promoter-enhancer looping [BP], cellular lactam catabolic process [BP], negative regulation of mast cell differentiation [BP], mitral valve formation [BP], negative regulation of interleukin-4 biosynthetic process [BP], tricuspid valve formation [BP]
CG_h1r2_promoter_p_PM_12_185_8			3	0.5	3.49E-04	EIF5A, MARC1	annulate lamellae [CC], nitrate reductase activity [MF]
CG_h1r2_promoter_p_PM_12_206_5			1	0.25	1.59E-04	AMHR2, LILRB1, DLST	negative regulation of osteoclast development [BP], HLA-A specific inhibitory MHC class I receptor activity [MF], negative regulation of CD8-positive, alpha-beta T cell activation [BP], negative regulation of natural killer cell mediated cytotoxicity [BP], negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [BP], negative regulation of transforming growth factor-beta secretion [BP], oxoglutarate dehydrogenase complex [CC], dihydrolipoyllysine-residue succinyltransferase activity [MF], transforming growth factor beta receptor activity, type II [MF], negative regulation of interleukin-12 secretion [BP], negative regulation of interleukin-10 secretion [BP], positive regulation of gamma-delta T cell activation involved in immune response [BP], negative regulation of interferon-beta secretion [BP], negative regulation of serotonin secretion [BP], HLA-B specific inhibitory MHC class I receptor activity [MF]
CG_h1r2_promoter_p_PM_12_262_8			1	0.25	1.14E-04	SOLH, L3MBTL1, KDM4B, FLRT2, EYA4, NSD1, CAPNS1, FSCN1, GAS2L1	calcium-dependent cysteine-type endopeptidase activity [MF], thyroid hormone receptor binding [MF], stress fiber [CC], chromatin modification [BP], protein binding, bridging [MF]
CG_h1r2_promoter_p_PM_12_324_8			2	0.5	9.07E-06	DHTKD1	oxoglutarate dehydrogenase (succinyl-transferring) activity [MF]
CG_h1r2_promoter_p_PM_12_158_4			1	0.25	4.10E-05	KLHL41	regulation of lateral pseudopodium assembly [BP]
CG_h1r2_promoter_p_PM_12_156_12			1	0.25	2.76E-05	ATN1, SLC5A5, CAT, PRKCA	catalase activity [MF], toxin receptor binding [MF], sodium:iodide symporter activity [MF], menopause [BP], positive regulation of dense core granule biogenesis [BP]
CG_h1r2_promoter_p_PM_12_69_4			1	0.25	9.80E-05	PBX3, DLAT	anterior compartment pattern formation [BP], dihydrolipoyllysine-residue acetyltransferase activity [MF], posterior compartment specification [BP]
CG_h1r2_promoter_p_PM_12_319_10			2	0.5	1.43E-04	ACE	regulation of systemic arterial blood pressure by renin-angiotensin [BP]
CG_h1r2_promoter_p_PM_12_64_9			2	0.5	2.09E-04	EXOSC7, DIS3L	3'-5'-exoribonuclease activity [MF], exosome (RNase complex) [CC]
CG_h1r2_promoter_p_PM_12_81_11			1	0.25	6.20E-05	TLR4, ALG1	chitobiosyldiphosphodolichol beta-mannosyltransferase activity [MF], positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway [BP], positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway [BP], detection of fungus [BP]
CG_h1r2_promoter_p_PM_12_70_4			1	0.25	7.13E-05	PHGDH	phosphoglycerate dehydrogenase activity [MF]
CG_h1r2_promoter_p_PM_12_253_12			1	0.25	3.40E-05	FAM20C, UGCG	glucosylceramide biosynthetic process [BP], ceramide glucosyltransferase activity [MF], odontoblast differentiation [BP], dentinogenesis [BP], osteoclast maturation [BP]
CG_h1r2_promoter_p_PM_12_123_7			2	0.5	7.99E-05	SIVA1	CD27 receptor binding [MF]
CG_h1r2_promoter_p_PM_12_187_15			2	0.5	1.44E-06	SLC26A4, CHRNB2	negative regulation of action potential [BP], iodide transmembrane transporter activity [MF], positive regulation of synaptic transmission, dopaminergic [BP], positive regulation of dopamine secretion [BP], synaptic transmission involved in micturition [BP], conditioned taste aversion [BP], lateral geniculate nucleus development [BP], vestibulocochlear nerve development [BP], sensory perception of sound [BP]
CG_h1r2_promoter_p_PM_12_18_8			2	0.5	3.10E-05	MAT2A, NLGN3, BMP2K, PPME1	regulation of long-term synaptic potentiation [BP], protein C-terminal methylesterase activity [MF], positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity [BP], regulation of terminal button organization [BP], phosphatase regulator activity [MF], methanogenesis [BP]
CG_h1r2_promoter_p_PM_12_251_12			2	0.5	2.65E-05	SAMM50	protein import into mitochondrial outer membrane [BP], mitochondrial sorting and assembly machinery complex [CC]
CG_h1r2_promoter_p_PM_12_255_11			1	0.25	4.63E-05	KIF19, NDEL1, DRD4	oligopeptidase activity [MF], plus-end specific microtubule depolymerization [BP], olfactory learning [BP], axonemal microtubule depolymerization [BP]
CG_h1r2_promoter_p_PM_12_264_6			2	0.5	3.08E-05	ASL, PARVB	establishment or maintenance of cell polarity regulating cell shape [BP], arginine biosynthetic process via ornithine [BP], argininosuccinate lyase activity [MF]
CG_h1r2_promoter_p_PM_12_270_8			1	0.25	7.07E-05	BASP1	positive regulation of metanephric ureteric bud development [BP], thorax and anterior abdomen determination [BP]
CG_h1r2_promoter_p_PM_12_214_10			2	0.5	1.04E-04	TXNRD1, FAAH	halogen metabolic process [BP], fatty acid amide hydrolase activity [MF], methylmercury metabolic process [BP], selenate reductase activity [MF]
CG_h1r2_promoter_p_PM_12_235_4			1	0.25	2.80E-04	TENM2, TRIM8	PML body [CC]
CG_h1r2_promoter_p_PM_12_124_4			2	0.5	4.61E-05	ADSSL1	adenylosuccinate synthase activity [MF], 'de novo' AMP biosynthetic process [BP]
CG_h1r2_promoter_p_PM_12_75_5			2	0.5	1.94E-04	EMG1, TACC2	rRNA (pseudouridine) methyltransferase activity [MF], cerebral cortex development [BP]
CG_h1r2_promoter_p_PM_12_92_6			1	0.25	2.18E-05	STT3A	co-translational protein modification [BP]
CG_h1r2_promoter_p_PM_12_224_4			1	0.25	1.30E-04	RGCC, SERPINF2, CUL4A	positive regulation of stress fiber assembly [BP], positive regulation of S phase of mitotic cell cycle [BP], positive regulation of collagen biosynthetic process [BP]
CG_h1r2_promoter_p_PM_12_168_6			1	0.25	1.84E-04	GAPDH, SERPINA5, ENTPD6	peptidyl-cysteine S-nitrosylase activity [MF], peptidyl-cysteine S-trans-nitrosylation [BP], protein C inhibitor-PLAT complex [CC], protein C inhibitor-thrombin complex [CC], protein C inhibitor-coagulation factor V complex [CC], protein C inhibitor-TMPRSS7 complex [CC], protein C inhibitor-coagulation factor Xa complex [CC], protein C inhibitor-KLK3 complex [CC], extracellular vesicular exosome [CC], protein C inhibitor-TMPRSS11E complex [CC], protein C inhibitor-coagulation factor XI complex [CC], guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity [MF], protein C inhibitor-PLAU complex [CC], protein C inhibitor-plasma kallikrein complex [CC]
CG_h1r2_promoter_p_PM_12_228_7			2	0.5	5.84E-05	IFI27, MSH3, ACSL3	dinucleotide insertion or deletion binding [MF], loop DNA binding [MF], double-strand/single-strand DNA junction binding [MF], MutSbeta complex [CC], mitochondrial outer membrane [CC], single guanine insertion binding [MF], positive regulation of Golgi to plasma membrane protein transport [BP], positive regulation of phosphatidylcholine biosynthetic process [BP], dinucleotide repeat insertion binding [MF]
CG_h1r2_promoter_p_PM_12_179_10			1	0.25	7.83E-05	KIAA1324, HTR6	negative regulation of gamma-aminobutyric acid secretion [BP], negative regulation of acetylcholine secretion [BP], positive regulation of vacuole organization [BP], positive regulation of autophagic vacuole assembly [BP]
CG_h1r2_promoter_p_PM_12_133_7			1	0.25	4.73E-05	CPS1	carbamoyl-phosphate synthase (ammonia) activity [MF], carbamoyl phosphate biosynthetic process [BP]
CG_h1r2_promoter_p_PM_12_31_9			2	0.25	1.12E-04	PGS1	CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity [MF]
CG_h1r2_promoter_p_PM_12_336_6			2	0.5	9.80E-05	FDFT1, PKD2	squalene synthase activity [MF], metanephric cortex development [BP], farnesyl-diphosphate farnesyltransferase activity [MF], positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [BP], renal artery morphogenesis [BP], metanephric cortical collecting duct development [BP]
CG_h1r2_promoter_p_PM_12_32_10			2	0.5	4.16E-05	AGL	isoamylase complex [CC]
CG_h1r2_promoter_p_PM_12_293_15			2	0.5	3.59E-05	TALDO1, NOD2, OS9	Hrd1p ubiquitin ligase complex [CC], negative regulation of interleukin-18 production [BP], muramyl dipeptide binding [MF], positive regulation of dendritic cell cytokine production [BP], detection of muramyl dipeptide [BP], sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity [MF], positive regulation of prostaglandin-E synthase activity [BP]
CG_h1r2_promoter_p_PM_12_189_11			2	0.5	1.35E-04	LPIN1, ARF6	ruffle organization [BP]
CG_h1r2_promoter_p_PM_12_221_7			2	0.5	1.37E-04	SLC6A8	creatine transmembrane transporter activity [MF], creatine transport [BP], creatine:sodium symporter activity [MF]
CG_h1r2_promoter_p_PM_12_196_10			2	0.5	1.71E-04	IL15	extrathymic T cell selection [BP]
CG_h1r2_promoter_p_PM_12_257_11			3	0.5	3.05E-04	OFD1, ODF2	centriole [CC]
CG_h1r2_promoter_p_PM_12_195_10			1	0.25	6.65E-05	GTPBP3, QTRTD1	tRNA modification [BP], queuosine biosynthetic process [BP]
CG_h1r2_promoter_p_PM_12_45_6			1	0.25	3.48E-05	ANKRD2, SGCD	muscle organ development [BP]
CG_h1r2_promoter_p_PM_12_118_14			1	0.25	1.31E-04	MTMR3, CLEC3B	kringle domain binding [MF], protein serine/threonine phosphatase activity [MF]
CG_h1r2_promoter_p_PM_12_33_6			2	0.25	2.78E-05	ATP2A1, GBAS	ATP biosynthetic process [BP], elevation of endoplasmic reticulum calcium ion concentration [BP], relaxation of skeletal muscle [BP], positive regulation of fast-twitch skeletal muscle fiber contraction [BP]
CG_h1r2_promoter_p_PM_12_129_8			1	0.25	2.85E-05	KIF3B, CDK5R2, PAFAH1B1	microtubule-based movement [BP], vesicle transport along microtubule [BP], kinesin complex [CC], layer formation in cerebral cortex [BP]
CG_h1r2_promoter_p_PM_12_212_9			3	0.5	4.34E-05	AXL, GSDMD	cellular response to extracellular stimulus [BP]
CG_h1r2_promoter_p_PM_12_320_9			2	0.5	5.34E-05	ADRB1, TBK1, MANF, MAP2K3	beta1-adrenergic receptor activity [MF], cardiac muscle contraction [BP], positive regulation of systemic arterial blood pressure [BP], positive regulation of the force of heart contraction by norepinephrine [BP], positive regulation of cell growth involved in cardiac muscle cell development [BP], vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure [BP], TRIF-dependent toll-like receptor signaling pathway [BP], MyD88-independent toll-like receptor signaling pathway [BP]
CG_h1r2_promoter_p_PM_12_80_8			1	0.25	1.68E-04	ADRA1B	vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure [BP]
CG_h1r2_promoter_p_PM_12_307_6			2	0.5	1.61E-04	CACNG5, P2RX2	detection of hypoxic conditions in blood by carotid body chemoreceptor signaling [BP], nickel cation binding [MF], postsynaptic density [CC], mercury ion binding [MF]
CG_h1r2_promoter_p_PM_12_73_10			2	0.5	1.52E-04	UTP20, CACNA1D	endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [BP], endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [BP], membrane repolarization involved in regulation of SA node cell action potential [BP], voltage-gated calcium channel activity involved in regulation of cardiac muscle cell action potential [MF], voltage-gated calcium channel activity involved in regulation of SA node cell action potential [MF]
CG_h1r2_promoter_p_PM_12_326_9			2	0.5	4.69E-05	CA9, MUC20	microvillus membrane [CC]
CG_h1r2_promoter_p_PM_12_252_17			2	0.5	5.60E-05	NLRP6, TMCO3	regulation of inflammatory response [BP], solute:hydrogen antiporter activity [MF]
CG_h1r2_promoter_p_PM_12_143_14			2	0.5	1.95E-04	DNAAF1, NKD1	positive regulation of non-canonical Wnt receptor signaling pathway via JNK cascade [BP], regulation of cilium beat frequency [BP], negative regulation of convergent extension involved in axis elongation [BP]
CG_h1r2_promoter_p_PM_12_93_9			2	0.5	4.54E-05	PLN, CIITA	negative regulation of calcium ion binding [BP], ATPase inhibitor activity [MF], regulation of relaxation of cardiac muscle [BP], negative regulation of collagen biosynthetic process [BP], negative regulation of calcium-transporting ATPase activity [BP], adrenergic receptor signaling pathway involved in heart process [BP], regulation of the force of heart contraction by cardiac conduction [BP]
CG_h1r2_promoter_p_PM_12_312_11			1	0.25	2.44E-04	RIMKLB	citrate-L-glutamate ligase activity [MF]
CG_h1r2_promoter_p_PM_12_127_7			2	0.5	3.98E-05	NLRP3, NOP58	snRNP protein import into nucleus [BP], negative regulation of interleukin-1 beta secretion [BP]
CG_h1r2_promoter_p_PM_12_284_13			3	0.75	1.12E-05	HPN, NLRP2, ADAMTS13	pilomotor reflex [BP], Pyrin domain binding [MF], protein processing [BP], basement membrane disassembly [BP]
CG_h1r2_promoter_p_PM_12_71_4			1	0.25	9.22E-05	KIAA1279, NAGK, LRRK2, RGCC, ACSL3	external side of mitochondrial outer membrane [CC], N-acetylglucosamine kinase activity [MF], negative regulation of exit from mitosis [BP], regulation of M/G1 transition of mitotic cell cycle [BP], GTP-dependent protein kinase activity [MF], positive regulation of phosphatidylcholine biosynthetic process [BP], negative regulation of branching morphogenesis of a nerve [BP], mitochondrion [CC]
CG_h1r2_promoter_p_PM_12_38_6			2	0.5	2.32E-04	SLC15A2	dipeptide transporter activity [MF], peptide:hydrogen symporter activity [MF], high affinity oligopeptide transporter activity [MF]
CG_h1r2_promoter_p_PM_12_20_14			1	0.25	1.92E-04	CHRM2, SSTR4, IL18BP	interleukin-18 binding [MF], G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [BP]
CG_h1r2_promoter_p_PM_12_259_12			2	0.5	3.36E-05	RSAD2	positive regulation of toll-like receptor 7 signaling pathway [BP], positive regulation of toll-like receptor 9 signaling pathway [BP]
CG_h1r2_promoter_p_PM_12_213_11			3	0.5	6.78E-05	ANXA9	acetylcholine receptor activity [MF]
CG_h1r2_promoter_p_PM_12_304_7			1	0.25	1.06E-04	IL13	interleukin-13 receptor binding [MF], positive regulation of connective tissue growth factor production [BP], positive regulation of lung goblet cell differentiation [BP], negative regulation of lung ciliated cell differentiation [BP], positive regulation of pancreatic stellate cell proliferation [BP], positive regulation of tyrosine phosphorylation of Stat6 protein [BP]
CG_h1r2_promoter_p_PM_12_121_7			2	0.5	4.58E-05	NDC80	phosphatidylinositol-mediated signaling [BP], condensed nuclear chromosome outer kinetochore [CC], Ndc80 complex [CC]
CG_h1r2_promoter_p_PM_12_277_4			2	0.5	1.24E-04	NNMT, NAT8L, NSUN4, HOGA1	oxalate metabolic process [BP], methyltransferase activity [MF], aspartate N-acetyltransferase activity [MF], nicotinamide N-methyltransferase activity [MF], 4-hydroxy-2-oxoglutarate aldolase activity [MF]
CG_h1r2_promoter_p_PM_12_182_6			1	0.25	5.27E-04	GLYATL1, ZNF8, ZNF556, ZNF555, GLI4, LRSAM1	zinc ion binding [MF], glutamine N-acyltransferase activity [MF], ubiquitin-dependent endocytosis [BP], non-lytic virus budding [BP]
CG_h1r2_promoter_p_PM_12_240_4			2	0.5	1.04E-04	DNM1L	dynamin polymerization involved in mitochondrial fission [BP], membrane fission involved in mitochondrial fission [BP]
CG_h1r2_promoter_p_PM_12_333_8			2	0.25	9.24E-05	IL18BP	interleukin-18 binding [MF]
CG_h1r2_promoter_p_PM_12_97_4			2	0.5	1.57E-04	TARBP2	miRNA loading onto RISC involved in gene silencing by miRNA [BP]
CG_h1r2_promoter_p_PM_12_19_9			1	0.25	5.45E-05	GCDH, CAMSAP3	glutaryl-CoA dehydrogenase activity [MF], microtubule minus-end binding [MF]
CG_h1r2_promoter_p_PM_12_334_5			2	0.5	5.30E-05	PROM2, CATSPERD	prominosome [CC], cilium membrane [CC]
CG_h1r2_promoter_p_PM_12_166_12			2	0.5	4.99E-04	PLG, C1S	proteolysis [BP], negative regulation of cell-cell adhesion mediated by cadherin [BP], serine-type endopeptidase activity [MF], positive regulation of fibrinolysis [BP]
CG_h1r2_promoter_p_PM_12_308_8			2	0.25	1.46E-04	IFNL1, PTEN	negative regulation of cyclin-dependent protein kinase activity involved in G1/S [BP], negative regulation of memory T cell differentiation [BP], negative regulation of synaptic vesicle clustering [BP], negative regulation of ribosome biogenesis [BP], postsynaptic density assembly [BP]
CG_h1r2_promoter_p_PM_12_10_6			1	0.25	8.46E-05	AASDHPPT, BCMO1, SMC2	beta-carotene 15,15'-monooxygenase activity [MF], meiotic chromosome segregation [BP], holo-[acyl-carrier-protein] synthase activity [MF], vitamin A biosynthetic process [BP]
CG_h1r2_promoter_p_PM_12_268_11			2	0.5	3.62E-05	CYP4B1, SLIT2, DIXDC1	fluorene oxygenase activity [MF], positive regulation of axonogenesis [BP], negative regulation of actin filament polymerization [BP], fluorene metabolic process [BP], induction of negative chemotaxis [BP], negative regulation of neutrophil chemotaxis [BP], corticospinal neuron axon guidance through spinal cord [BP]
CG_h1r2_promoter_p_PM_12_225_7			2	0.25	5.92E-05	NAALAD2, EID1, BCAM	histone acetyltransferase regulator activity [MF], N-formylglutamate deformylase activity [MF], laminin receptor activity [MF]
CG_h1r2_promoter_p_PM_12_1_10			1	0.25	1.36E-04	RIPK2	response to interleukin-18 [BP], cellular response to peptidoglycan [BP]
CG_h1r2_promoter_p_PM_12_16_8			1	0.25	1.13E-04	CTTN, FMN2, FBLIM1	cell cortex [CC]
CG_h1r2_promoter_p_PM_12_243_14			2	0.5	6.75E-05	ATF6, ACER3, WNT8A	spinal cord anterior/posterior patterning [BP], phytosphingosine biosynthetic process [BP], polarity specification of anterior/posterior axis [BP], regulation of transcription involved in anterior/posterior axis specification [BP], polarity specification of proximal/distal axis [BP], establishment of organ orientation [BP], positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response [BP], phytoceramidase activity [MF], canonical Wnt receptor signaling pathway involved in neural crest cell differentiation [BP]
CG_h1r2_promoter_p_PM_12_125_4			1	0.25	3.94E-05	ALPL	cementum mineralization [BP]
CG_h1r2_promoter_p_PM_12_21_9			2	0.25	8.81E-05	AK4, PPP2R1A	peptidyl-serine dephosphorylation [BP], tetracycline metabolic process [BP], carbon tetrachloride metabolic process [BP]
CG_h1r2_promoter_p_PM_12_150_10			3	0.5	1.17E-05	SGPL1, TGM4, CARM1, TMEM204, ISG20, IFNL1	exoribonuclease II activity [MF], sphinganine-1-phosphate aldolase activity [MF], interleukin-28 receptor binding [MF], negative regulation of memory T cell differentiation [BP], histone methyltransferase activity (H3-R17 specific) [MF], histone H3-R17 methylation [BP], regulation of vascular endothelial growth factor receptor signaling pathway [BP], protein polyamination [BP]
CG_h1r2_promoter_p_PM_12_61_8			2	0.5	7.94E-05	CAMSAP3, POLD1	delta DNA polymerase complex [CC], DNA replication proofreading [BP], microtubule minus-end binding [MF]
CG_h1r2_promoter_p_PM_12_47_17			2	0.5	8.28E-05	HIF1AN, HMGA2, DLL3, FPGS, GABRA5, IKZF1, BPTF	chromatin modification [BP], positive regulation of multicellular organism growth [BP], brain development [BP], cochlea development [BP], mesoderm development [BP], chromatin organization [BP], Notch binding [MF]
CG_h1r2_promoter_p_PM_12_122_15			2	0.5	9.52E-05	DUT	dUTP diphosphatase activity [MF], dUMP biosynthetic process [BP]
CG_h1r2_promoter_p_PM_12_152_12			2	0.5	1.21E-04	MAP2K1, PDZK1, GATA3, FSHB, PINK1	negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation [BP], positive regulation of cell migration [BP], negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation [BP], follicle-stimulating hormone activity [MF], scavenger receptor binding [MF], negative regulation of cell proliferation involved in mesonephros development [BP], receptor signaling protein tyrosine phosphatase activity [MF], regulation of histone H3-K27 methylation [BP], C3HC4-type RING finger domain binding [MF]
CG_h1r2_promoter_p_PM_12_13_7			2	0.5	4.94E-05	ALOX5AP, WNT8B	negative regulation of anterior neural cell fate commitment of the neural plate by Wnt receptor signaling pathway [BP], arachidonate 5-lipoxygenase activity [MF]
CG_h1r2_promoter_p_PM_12_30_8			2	0.5	5.91E-05	PPIA, PIN4, TNFRSF8	bent DNA binding [MF], positive regulation of TRAIL biosynthetic process [BP], uncoating of virus [BP], peptidyl-prolyl cis-trans isomerase activity [MF]
CG_h1r2_promoter_p_PM_12_272_8			2	0.5	7.47E-05	RNMT	mRNA (guanine-N7-)-methyltransferase activity [MF]
CG_h1r2_promoter_p_PM_12_286_10			1	0.25	8.61E-05	PIGB, CYP21A2, ARF6, TTYH1, DIO1, EPHX1	filopodium membrane [CC], endoplasmic reticulum membrane [CC]
CG_h1r2_promoter_p_PM_12_146_11			2	0.5	1.35E-05	MTHFD1	methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [MF], methylenetetrahydrofolate dehydrogenase (NADP+) activity [MF], histidine biosynthetic process [BP], formate-tetrahydrofolate ligase activity [MF], methenyltetrahydrofolate cyclohydrolase activity [MF]
CG_h1r2_promoter_p_PM_12_29_5			1	0.25	1.41E-05	OR10J1, OR2L3, GLP1R, OR4F15	olfactory receptor activity [MF], transmembrane signaling receptor activity [MF], G-protein coupled receptor activity [MF], glucagon receptor activity [MF]
CG_h1r2_promoter_p_PM_12_229_7			2	0.5	1.68E-04	LIAS, BAG4, PML, NUBP1, EDDM3A, CSE1L, CASQ1	negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [BP], terminal cisterna lumen [CC], sperm displacement [BP], lipoate synthase activity [MF], 4 iron, 4 sulfur cluster binding [MF], regulation of calcium ion transport into cytosol [BP], extrinsic to endoplasmic reticulum membrane [CC], negative regulation of translation in response to oxidative stress [BP], importin-alpha export receptor activity [MF]
CG_h1r2_promoter_p_PM_12_130_10			3	0.75	6.00E-05	PLN, HSF1	negative regulation of calcium ion binding [BP], ATPase inhibitor activity [MF], regulation of relaxation of cardiac muscle [BP], negative regulation of calcium-transporting ATPase activity [BP], RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [MF], adrenergic receptor signaling pathway involved in heart process [BP], regulation of the force of heart contraction by cardiac conduction [BP]
CG_h1r2_promoter_p_PM_12_77_6			2	0.5	8.42E-05	AANAT	aralkylamine N-acetyltransferase activity [MF]
CG_h1r2_promoter_p_PM_12_11_9			1	0.25	7.56E-05	DAOA, CDS1	negative regulation of D-amino-acid oxidase activity [BP], phosphatidate cytidylyltransferase activity [MF]
CG_h1r2_promoter_p_PM_12_306_16			1	0.25	6.18E-05	PCDHB1, PCDH7, TENM3	homophilic cell adhesion [BP]
CG_h1r2_promoter_p_PM_12_96_8			2	0.5	1.87E-04	LDLRAP1, MGAT5B	alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [MF], receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport [BP], clathrin adaptor activity [MF]
CG_h1r2_promoter_p_PM_12_242_8			2	0.5	5.14E-05	CCKBR	gastrin receptor activity [MF], type B gastrin/cholecystokinin receptor binding [MF]
CG_h1r2_promoter_p_PM_12_208_5			2	0.5	8.65E-05	UNC13B, PSEN1	neuromuscular junction [CC]
CG_h1r2_promoter_p_PM_12_302_10			2	0.5	1.67E-04	FPGS, PHACTR4	protein phosphatase type 1 activator activity [MF], tetrahydrofolylpolyglutamate synthase activity [MF], negative regulation of integrin-mediated signaling pathway [BP]
CG_h1r2_promoter_p_PM_12_59_10			2	0.25	3.47E-04	F2, FOXO3	positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway [BP], initiation of primordial ovarian follicle growth [BP]
CG_h1r2_promoter_p_PM_12_5_13			2	0.5	5.73E-05	DNASE1	deoxyribonuclease I activity [MF]
CG_h1r2_promoter_p_PM_12_188_7			1	0.25	5.29E-05	ACSF3, MED25, PUS1	positive regulation of chromatin binding [BP], positive regulation of mediator complex assembly [BP], pseudouridylate synthase activity [MF], malonyl-CoA synthetase activity [MF], malonate catabolic process [BP]
CG_h1r2_promoter_p_PM_12_297_4			1	0.25	5.32E-05	DRAXIN, KIF3B	commissural neuron differentiation in spinal cord [BP], plus-end kinesin complex [CC]
CG_h1r2_promoter_p_PM_12_114_12			2	0.5	6.50E-05	RBBP4	CAF-1 complex [CC]
CG_h1r2_promoter_p_PM_12_176_6			1	0.25	1.50E-05	ACO2, ZFPM1	regulation of definitive erythrocyte differentiation [BP], primitive erythrocyte differentiation [BP], transcriptional activation by promoter-enhancer looping [BP], isocitrate hydro-lyase (cis-aconitate-forming) activity [MF], negative regulation of mast cell differentiation [BP], citrate hydro-lyase (cis-aconitate-forming) activity [MF], mitral valve formation [BP], 3 iron, 4 sulfur cluster binding [MF], negative regulation of interleukin-4 biosynthetic process [BP], tricuspid valve formation [BP]
CG_h1r2_promoter_p_PM_12_317_8			3	0.5	1.18E-04	CHIA, GFM1	mitochondrial translational elongation [BP], cell wall chitin metabolic process [BP]
CG_h1r2_promoter_p_PM_12_184_8			1	0.25	2.24E-05	MCHR1, GPIHBP1	positive regulation of chylomicron remnant clearance [BP], chylomicron binding [MF], lipase binding [MF], melanin-concentrating hormone receptor activity [MF]
CG_h1r2_promoter_p_PM_12_137_7			1	0.25	3.61E-05	NOG, KHK	negative regulation of cytokine activity [BP], fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP], ketohexokinase activity [MF], regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [BP]
CG_h1r2_promoter_p_PM_12_135_13			2	0.5	1.73E-04	PLN, PLCG2	follicular B cell differentiation [BP], regulation of the force of heart contraction by cardiac conduction [BP], regulation of relaxation of cardiac muscle [BP], negative regulation of calcium-transporting ATPase activity [BP]
CG_h1r2_promoter_p_PM_12_102_8			2	0.5	1.09E-05	RPA1, RAD51C, UBIAD1	vitamin K biosynthetic process [BP], female meiosis sister chromatid cohesion [BP], crossover junction endodeoxyribonuclease activity [MF], meiosis [BP], menaquinone biosynthetic process [BP]
CG_h1r2_promoter_p_PM_12_198_10			2	0.5	3.85E-05	RAB33B, PNPLA3	mono-olein transacylation activity [MF], regulation of retrograde vesicle-mediated transport, Golgi to ER [BP], diolein transacylation activity [MF]
CG_h1r2_promoter_p_PM_12_84_10			2	0.5	4.54E-05	AIP, CAT, HMBS	GAF domain binding [MF], peptidyl-pyrromethane cofactor linkage [BP], catalase activity [MF], negative regulation of cyclic-nucleotide phosphodiesterase activity [BP], hydroxymethylbilane synthase activity [MF], menopause [BP]
CG_h1r2_promoter_p_PM_12_161_10			1	0.25	1.52E-04	PPP1CB	myosin phosphatase activity [MF], myosin-light-chain-phosphatase activity [MF]
CG_h1r2_promoter_p_PM_12_209_9			1	0.25	2.24E-05	ADPRHL2, ACTN4, PSAT1	O-phospho-L-serine:2-oxoglutarate aminotransferase activity [MF], pyridoxine biosynthetic process [BP], poly(ADP-ribose) glycohydrolase activity [MF], positive regulation of pinocytosis [BP]
CG_h1r2_promoter_p_PM_12_299_6			2	0.5	1.66E-04	ADSL	N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity [MF], (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity [MF]
CG_h1r2_promoter_p_PM_12_201_10			1	0.25	3.12E-04	AKR1D1	bile acid catabolic process [BP], delta4-3-oxosteroid 5beta-reductase activity [MF]
CG_h1r2_promoter_p_PM_12_246_17			3	0.5	1.70E-05	CENPF, CENPO	mitotic prometaphase [BP], kinetochore [CC], condensed chromosome kinetochore [CC]
CG_h1r2_promoter_p_PM_12_159_9			2	0.5	1.17E-04	G6PC3, G6PC2, PEA15	hexose transport [BP], carbohydrate transport [BP], glucose transport [BP], glucose-6-phosphatase activity [MF]
CG_h1r2_promoter_p_PM_12_241_8			1	0.25	3.96E-05	NUDT1	ATP diphosphatase activity [MF]
CG_h1r2_promoter_p_PM_12_100_9			4	0.75	5.38E-05	PPP1CB, ABCC1, PSMC5, ATP5C1	myosin phosphatase activity [MF], myosin-light-chain-phosphatase activity [MF], nuclear proteasome complex [CC], thyrotropin-releasing hormone receptor binding [MF], ATP catabolic process [BP], ATPase activity [MF]
CG_h1r2_promoter_p_PM_12_62_10			1	0.25	1.85E-04	ATCAY, UBE2B	negative regulation of histone phosphorylation [BP], negative regulation of glutamate metabolic process [BP], positive regulation of reciprocal meiotic recombination [BP]
CG_h1r2_promoter_p_PM_12_309_9			1	0.25	7.35E-05	AKR1C4, SLC5A3, ABCE1	myo-inositol:sodium symporter activity [MF], androsterone dehydrogenase (B-specific) activity [MF], electron carrier activity [MF], ribonuclease inhibitor activity [MF], chlordecone reductase activity [MF]
CG_h1r2_promoter_p_PM_12_192_5			2	0.5	1.21E-04	SLC9A3R1, COMT, POU3F3	positive regulation of homocysteine metabolic process [BP], renal phosphate ion absorption [BP], metanephric macula densa development [BP], bile acid secretion [BP]
CG_h1r2_promoter_p_PM_12_94_4			1	0.25	2.12E-04	RALA, PRLH	Edg-2 lysophosphatidic acid receptor binding [MF], reduction of food intake in response to dietary excess [BP], prolactin-releasing peptide receptor binding [MF]
CG_h1r2_promoter_p_PM_12_276_9			1	0.25	5.57E-05	TP63	ectoderm and mesoderm interaction [BP], squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [BP], female genitalia morphogenesis [BP], negative regulation of keratinocyte differentiation [BP], cloacal septation [BP]
CG_h1r2_promoter_p_PM_12_54_8			2	0.5	2.99E-05	WNT8A, IVD	isovaleryl-CoA dehydrogenase activity [MF], polarity specification of anterior/posterior axis [BP]
CG_h1r2_promoter_p_PM_12_207_11			3	0.5	5.64E-05	SLC1A3, UTS2R	high-affinity glutamate transmembrane transporter activity [MF], urotensin II receptor activity [MF]
CG_h1r2_promoter_p_PM_12_335_9			2	0.5	5.82E-05	TNFRSF8	positive regulation of TRAIL biosynthetic process [BP]
CG_h1r2_promoter_p_PM_12_222_16			2	0.5	1.20E-04	CACNA1G	response to nickel cation [BP]
CG_h1r2_promoter_p_PM_12_157_11			2	0.5	2.99E-04	BBOX1, MOCOS	gamma-butyrobetaine dioxygenase activity [MF], Mo-molybdopterin cofactor sulfurase activity [MF]
CG_h1r2_promoter_p_PM_12_285_9			2	0.5	3.48E-05	MLH1, RASGRP3	Rap GTPase activator activity [MF], chiasma [CC], negative regulation of mitotic recombination [BP], spindle midzone assembly involved in meiosis [BP], meiotic metaphase I plate congression [BP], guanine/thymine mispair binding [MF], MutLbeta complex [CC]
CG_h1r2_promoter_p_PM_12_194_9			1	0.25	2.54E-04	NAGK, SEPT7	N-acetylglucosamine kinase activity [MF], N-acetylmannosamine metabolic process [BP], regulation of embryonic cell shape [BP]
CG_h1r2_promoter_p_PM_12_170_4			2	0.5	6.23E-05	ARHGAP10, NCK2	cytoskeletal adaptor activity [MF]
CG_h1r2_promoter_p_PM_12_230_11			2	0.25	7.56E-05	SUPV3L1, CHAMP1	mitochondrial RNA surveillance [BP], chromatin maintenance [BP], mitochondrial ncRNA surveillance [BP], mitochondrial RNA 3'-end processing [BP], mitochondrial degradosome [CC], 3'-5' RNA helicase activity [MF], mitochondrial mRNA catabolic process [BP], positive regulation of mitochondrial RNA catabolic process [BP], mitochondrial mRNA surveillance [BP], sister chromatid biorientation [BP]
CG_h1r2_promoter_p_PM_12_165_5			1	0.25	1.00E-04	ALLC	allantoicase activity [MF], allantoin catabolic process [BP]
CG_h1r2_promoter_p_PM_12_294_6			1	0.25	2.61E-04	CLEC9A, BHLHE40	entrainment of circadian clock by photoperiod [BP], receptor-mediated endocytosis [BP]
CG_h1r2_promoter_p_PM_12_144_8			2	0.25	1.04E-04	ADRA2A, RAPGEF4, VIL1, STX17, ITPR3, BRPF3	energy reserve metabolic process [BP], exocytosis [BP], epidermal growth factor receptor signaling pathway [BP], platelet activation [BP], regulation of insulin secretion [BP], insulin secretion [BP]
CG_h1r2_promoter_p_PM_12_315_5			2	0.5	3.51E-05	TTLL3, IDUA	protein-glycine ligase activity [MF], protein-glycine ligase activity, initiating [MF], protein polyglycylation [BP], L-iduronidase activity [MF]
CG_h1r2_promoter_p_PM_12_91_6			2	0.5	6.46E-05	SDCBP, CSF1	mammary gland fat development [BP], interleukin-5 receptor complex [CC]
CG_h1r2_promoter_p_PM_12_218_8			2	0.5	2.70E-04	CPS1	carbamoyl-phosphate synthase (ammonia) activity [MF]
CG_h1r2_promoter_p_PM_12_163_12			2	0.5	1.96E-04	MPG	DNA-7-methylguanine glycosylase activity [MF], DNA-7-methyladenine glycosylase activity [MF], DNA-3-methylguanine glycosylase activity [MF], DNA-3-methyladenine glycosylase activity [MF]
CG_h1r2_promoter_p_PM_12_172_8			2	0.5	3.18E-04	MAVS, IQGAP1, MFF, CDH1	peroxisome [CC], positive regulation of transcription factor import into nucleus [BP], lateral plasma membrane [CC], regulation of peroxisome organization [BP]
CG_h1r2_promoter_p_PM_12_167_9			1	0.25	2.62E-05	GALK2, PPP2R1A	peptidyl-serine dephosphorylation [BP], N-acetylgalactosamine kinase activity [MF], galactokinase activity [MF]
CG_h1r2_promoter_p_PM_12_175_8			2	0.25	9.37E-05	GET4, PARPBP, RNF111	negative regulation of double-strand break repair via homologous recombination [BP], tail-anchored membrane protein insertion into ER membrane [BP], SUMO polymer binding [MF], BAT3 complex [CC]
CG_h1r2_promoter_p_PM_12_27_13			2	0.5	4.88E-05	RRAGA, RASL11A, ARL8B	GTP binding [MF]
CG_h1r2_promoter_p_PM_12_301_6			3	0.5	3.21E-05	ATAT1, PTPRO	tubulin N-acetyltransferase activity [MF], slit diaphragm assembly [BP], negative regulation of retinal ganglion cell axon guidance [BP]
CG_h1r2_promoter_p_PM_12_6_9			2	0.5	3.81E-05	CRHBP, PPARD	linoleic acid binding [MF], negative regulation of corticotropin secretion [BP], negative regulation of corticotropin-releasing hormone receptor activity [BP]
CG_h1r2_promoter_p_PM_12_313_11			2	0.5	4.46E-05	NOX5, DSE	regulation of fusion of sperm to egg plasma membrane [BP], chondroitin-glucuronate 5-epimerase activity [MF]
CG_h1r2_promoter_p_PM_12_142_10			2	0.5	1.49E-04	ELMO3	phagocytosis [BP]
CG_h1r2_promoter_p_PM_12_237_12			2	0.5	1.33E-04	SMARCA2	aortic smooth muscle cell differentiation [BP]
CG_h1r2_promoter_p_PM_12_86_6			2	0.5	4.38E-05	CPLX3, CFLAR, CPLX2	syntaxin binding [MF], negative regulation of myoblast fusion [BP], synaptic vesicle exocytosis [BP]
CG_h1r2_promoter_p_PM_12_4_8			1	0.25	1.30E-04	HIF1A, GNA15	phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway [BP], neural fold elevation formation [BP], B-1 B cell homeostasis [BP], intestinal epithelial cell maturation [BP], positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [BP], connective tissue replacement involved in inflammatory response wound healing [BP], positive regulation of chemokine-mediated signaling pathway [BP]
CG_h1r2_promoter_p_PM_12_99_7			1	0.25	1.19E-04	PRMT1, MIXL1	positive regulation of mesoderm development [BP], snoRNP binding [MF], [cytochrome c]-arginine N-methyltransferase activity [MF]
CG_h1r2_promoter_p_PM_12_296_11			1	0.25	1.47E-04	SNTG2	syntrophin complex [CC]
CG_h1r2_promoter_p_PM_12_22_7			2	0.25	8.22E-05	LSM11	U7 snRNA binding [MF]
CG_h1r2_promoter_p_PM_12_40_4			1	0.25	7.50E-05	ERCC4	nucleotide-excision repair factor 1 complex [CC]
CG_h1r2_promoter_p_PM_12_245_5			2	0.5	2.53E-04	ZAP70	beta selection [BP], T cell aggregation [BP]
CG_h1r2_promoter_p_PM_12_287_14			2	0.5	1.28E-05	NTRK2	brain-derived neurotrophic factor binding [MF], brain-derived neurotrophic factor-activated receptor activity [MF], brain-derived neurotrophic factor receptor signaling pathway [BP], response to auditory stimulus [BP]